Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers

PURPOSE: We developed and validated a contrast-enhanced spectral mammography (CESM)-based radiomics nomogram to predict neoadjuvant chemotherapy (NAC)-insensitive breast cancers prior to treatment. METHODS: We enrolled 117 patients with breast cancer who underwent CESM examination and NAC treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Wang, Zhongyi, Lin, Fan, Ma, Heng, Shi, Yinghong, Dong, Jianjun, Yang, Ping, Zhang, Kun, Guo, Na, Zhang, Ran, Cui, Jingjing, Duan, Shaofeng, Mao, Ning, Xie, Haizhu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937952/
https://ncbi.nlm.nih.gov/pubmed/33692950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.605230
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados